Bleeding Post Thyroidectomy
- The incidence of symptomatic hemorrhage:
- Requiring reintervention amounts to 0.1% to 1.5%
- Post-operative bleeding will characteristically be prefaced by:
- No specific perioperative risk factors:
- That would allow identification of the high-risk patient population for this potentially lethal complication are known
- High surgical volume:
- Does not reduce the incidence of hematoma formation:
- Consequently, the key issue of prevention is:
- Attention to anatomic detail and careful hemostasis during surgery
- If the surgeon is uncertain about the dryness of the operative field:
- A Valsalva maneuver:
- Which elevates the intrapulmonary pressure to 40 cm H20:
- Facilitates recognition of bleeding vessels:
- Can be performed prior to wound closure
- Routine use of suction drains:
- Does not prevent postoperative cervical bleeding
- In the majority of patients, symptomatic hemorrhage:
- Occurs between 6 and 12 hours after the initial operation
- Since in approximately 20% of cases the onset of hematoma symptoms:
- Is reported beyond 24 hours postoperatively:
- Ambulatory surgery with a 4- to 8-hour observation period might harbor risk of delayed intervention
- Once recognized:
- The wound should be deliberately re-opened, and the hematoma evacuated
- In case of significant respiratory distress:
- Emergency bedside hematoma evacuation, if necessary, in combination with endotracheal intubation, is required
- The requirement for tracheotomy either in the emergency setting or due to persisting airway obstruction after hematoma removal is generally a rare event
- Reference:
- Burkey SH, et al (2001) Reexploration for symptomatic he- matomas after cervical exploration. Surgery 130:914–920
Like this:
Like Loading...
Related
Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO
My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida.
I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016.
Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida.
Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.
View all posts by Rodrigo Arrangoiz MS, MD, FACS, FSSO